Healthcare
Eris Lifesciences Limited (ERIS)
Eris Lifesciences Limited (ERIS) is an NSE-listed Healthcare company. latest close ₹1,328.2, 1-day return +0.2%, 1-week return -2.2%. This page shows price, returns, and technical signals from QUANTSCASE. Informational only — not investment advice.
Data as of 20 Aug 2026
For informational and educational purposes only. Not investment advice. QUANTSCASE is a stock screener, not a SEBI-registered investment adviser, research analyst, or portfolio manager. Terms
Price & returns
- Last close
- ₹1,328.2
- 1-day return
- +0.2%
- 1-week return
- -2.2%
- 1-month return
- -7.8%
Technical signals
Latest daily indicators. These are screen readings, not buy or sell calls.
- RSI (14)
- 33.9
- ADX (14)
- 69.4
- ROC 10
- -3.9%
- vs 52W high
- -27.0%
Fundamentals snapshot
Latest fields from our NSE fundamentals table. Figures can lag the live tape.
- Market cap
- ₹18,407 Cr
- P/E
- 28.4
- P/B
- 4.65
- ROE
- —
- D/E
- 60.55
- Net margin
- 20.0%
- Rev. growth YoY
- 12.6%
- Div. yield
- 109.0%
- 52W high
- ₹1,818.8
- 52W low
- ₹1,200
- EPS (TTM)
- ₹46.81
Live signals
Built from the latest price, 1-day / 1-week return, and technical snapshot — not a news calendar.
- signal
1-day return +0.2%
Latest 1-day price change versus the previous close.
- signal
1-week return -2.2%
Price change over the last five trading sessions.
- signal
ADX(14) 69 — trend in force
ADX above 25 usually means a directional move is underway.
News & screener mentions
Recent QUANTSCASE daily posts that listed ERIS.
No recent screener posts mentioned ERIS yet. New daily posts will show up here automatically.
